NEUCA S.A. (WSE: NEU)

Market Cap	3.76B
Revenue (ttm)	12.13B
Net Income (ttm)	164.59M
Shares Out	4.48M
EPS (ttm)	36.33
PE Ratio	23.15
Forward PE	17.92
Dividend	14.50 (1.72%)
Ex-Dividend Date	Jun 12, 2024

Volume	1,617
Open	806.00
Previous Close	806.00
Day's Range	806.00 - 855.00
52-Week Range	630.00 - 969.00
Beta	0.42
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 19, 2024

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company owns and produces Rx, OTC medicines, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brand names to pharmacists, medical doctors,...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1990
• Employees: 4,633
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NEU

Financial Performance

In 2023, NEUCA's revenue was 11.81 billion, an increase of 5.17% compared to the previous year's 11.23 billion. Earnings were 146.27 million, an increase of 6.58%.